161 related articles for article (PubMed ID: 10910907)
21. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3.
Nagata Y; Nishida E; Todokoro K
Blood; 1997 Apr; 89(8):2664-9. PubMed ID: 9108383
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
Stadheim TA; Xiao H; Eastman A
Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-terminal protein kinase pathway.
Song BJ; Soh Y; Bae M; Pie J; Wan J; Jeong K
Chem Biol Interact; 2001 Jan; 130-132(1-3):943-54. PubMed ID: 11306108
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
27. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
Chuang SM; Liou GY; Yang JL
Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
[TBL] [Abstract][Full Text] [Related]
28. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.
Wang X; Martindale JL; Liu Y; Holbrook NJ
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):291-300. PubMed ID: 9657968
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
30. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis.
Willaime-Morawek S; Brami-Cherrier K; Mariani J; Caboche J; Brugg B
Neuroscience; 2003; 119(2):387-97. PubMed ID: 12770554
[TBL] [Abstract][Full Text] [Related]
31. Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38.
Wolfman JC; Palmby T; Der CJ; Wolfman A
Mol Cell Biol; 2002 Mar; 22(5):1589-606. PubMed ID: 11839824
[TBL] [Abstract][Full Text] [Related]
32. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells.
Chuang SM; Yang JL
Mol Cell Biochem; 2001 Jun; 222(1-2):85-95. PubMed ID: 11678615
[TBL] [Abstract][Full Text] [Related]
33. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
35. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
[TBL] [Abstract][Full Text] [Related]
36. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis.
Qiao D; Stratagouleas ED; Martinez JD
Carcinogenesis; 2001 Jan; 22(1):35-41. PubMed ID: 11159738
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells.
Abutin RM; Chen J; Lung TK; Lloyd JA; Sawyer ST; Harada H
Exp Hematol; 2009 Feb; 37(2):151-8. PubMed ID: 19100675
[TBL] [Abstract][Full Text] [Related]
38. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
39. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
40. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases.
Caughlan A; Newhouse K; Namgung U; Xia Z
Toxicol Sci; 2004 Mar; 78(1):125-34. PubMed ID: 14691213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
